J. Andrew Mackay

Dr. J. Andrew Mackay

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2010 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
SJSiti M. Janib
Siti M. Janib
AMAra S. Moses
Ara S. Moses
JMJ. Andrew Mackay
J. Andrew Mackay

1 October 2016 in Journal of Controlled Release
Verified
Journal Article
Closed access
JDJordan Despanie
Jordan Despanie
JDJugal P. Dhandhukia
Jugal P. Dhandhukia
Sarah Hamm-AlvarezSarah Hamm-Alvarez
Sarah Hamm-Alvarez
JMJ. Andrew Mackay
J. Andrew Mackay

1 November 2013 in Journal of Controlled Release
Verified
Journal Article
Closed access
PSPu Shi
Pu Shi
SASuhaas Aluri
Suhaas Aluri
YLYi-An Lin
Yi-An Lin
MSMihir Shah
Mihir Shah
MEMaria Edman
Maria Edman
JMJ. Andrew Mackay
J. Andrew Mackay

20 March 2012 in Protein Science
Verified
Journal Article
Open access
PDF file
MSMihir Shah
Mihir Shah
PHPang‐Yu Hsueh
Pang‐Yu Hsueh
GSGuoyong Sun
Guoyong Sun
HCHo Yon Chang
Ho Yon Chang
SJSiti M. Janib
Siti M. Janib
JMJ. Andrew Mackay
J. Andrew Mackay
Protein polymers are repetitive polypeptides produced by ribosomal biosynthetic pathways; furthermore, they offer emerging opportunities in drug and biopharmaceutical delivery. As for any polymer, biodegradation is one of the most important determinants affecting how a protein polymer can be utilized in the body. This study was designed to characterize the proteolytic biodegradation for a library of protein polymers derived from the human tropoelastin, the Elastin‐like polypeptides (ELPs). ELPs are of particular interest for controlled drug delivery because they reversibly transition from soluble to insoluble above an inverse phase transition temperature (Tt). More recently, ELP block copolymers have been developed that can assemble into micelles; however, it remains unclear if proteases can act on these ELP nanoparticles. For the first time, we demonstrate that ELP nanoparticles can be degraded by two model proteases and that comparable proteolysis occurs after cell uptake into a transformed culture of murine hepatocytes. Both elastase and collagenase endopeptidases can proteolytically degrade soluble ELPs. To our surprise, the ELP phase transition was protective against collagenase but not to elastase activity. These findings enhance our ability to predict how ELPs will biodegrade in different physiological microenvironments and are essential to develop protein polymers into biopharmaceuticals.

30 September 2009 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
SASuhaas Aluri
Suhaas Aluri
SJSiti M. Janib
Siti M. Janib
JMJ. Andrew Mackay
J. Andrew Mackay

10 June 2013 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
SJS. M. Janib
S. M. Janib
MPM. F. Pastuszka
M. F. Pastuszka
SAS. Aluri
S. Aluri
ZFZ. Folchman-Wagner
Z. Folchman-Wagner
PHP. Y. Hsueh
P. Y. Hsueh
JMJ. Andrew Mackay
J. Andrew Mackay
Protein polymers can assemble switchable nanostructures with emerging applications as biomaterials and nanomedicines. For example, above a critical micelle temperature (CMT) some elastin-like polypeptide (ELP) diblock copolymers assemble spherical nanoparticles, which may modulate cellular internalization and in vivo biodistribution. To achieve engineering-level control over their properties, this report explores a comprehensive library of ELP monoblock and diblock polymers. For the first time, we report that a surprisingly high core molecular weight is required for stable nanoparticle formation; furthermore, nanoparticle size depends on polymer molecular weight. A mathematical model was developed to characterize four ELP monoblock libraries and to predict the phase behavior of corresponding diblock copolymers. The CMT was almost entirely dependent on the hydrophobic core ELP, while the bulk phase transition temperature (Tt,bulk) depends predominantly on the hydrophilic block. Nanoparticle assembly was accompanied by a conversion in secondary structure of the hydrophobic block from random coil and β-sheets to type-2 β-turns. For the first time, this report enables the rational design of ELP protein polymer nanoparticles with physico–chemico properties that will be suitable for biological applications.